baber/WOPTO huggingface dataset:
Patent FI-20065362-A0 (FI)
Inventor: KOMONEN JUSSI
Filed: 2006-05-29
Abstract: A distributed file system comprising a plurality of apparatuses arranged to store backup data received from other apparatuses of the distributed file system, wherein a first apparatus is arranged to fragment a data file to be archived into a plurality of subunits. The first apparatus carries out the fragmentation according to a predetermined fragmentation scheme such that the recovery of original data file requires more than one, but less than all subunits. Then the apparatus establishes peer-to-peer connections to at least two apparatuses of the distributed file system, and distributes the fragmented subunits of the data file to said at least two apparatuses to be backed up.
Patent IL-101139-A0 (IL)
Title: Imidazoacridines and their antineoplastic use
IPC: A61K31/4745
Filed: 1992-03-04
Abstract: Compounds of formula I <CHEM>  in which: R represents: -OH or -OR min , wherein R min  represents C1-C6 alkyl, R1<a> and R1<b>, which may be identical or different, represent hydrogen or C1-C6 alkyl, unsubstituted or substituted by a hydroxyl, an amino, a N min -alkylamino or a N min ,N min -dialkylamino group, such N min -alkyl groups containing 1-4 carbon atoms,     n is 2-5 and     R2 represents hydrogen, or straight chain C1-4 alkyl, in the form of a free base or a pharmaceutically acceptable acid addition salt or an N-oxide are useful in antineoplastic treatment and prophylaxis, especially of leukaemias.
Patent IL-104026-A0 (IL)
Title: Pharmaceutical composition for the improvement of dysuria comprising xanthine derivatives
IPC: A61K31/52
Filed: 1992-12-08
Abstract: Pharmaceutical compositions for the improvement of dysuria comprising a pharmaceutical carrier and a therapeutically effective amount of a xanthine derivative represented by the general formula I <CHEM> wherein R1 denotes a group of the formula R4-CO- or R5R6(OH)C-or a carboxyl group, wherein R4 and R5 independently denote an alkyl group having 1-3 carbon atoms, and R6 denotes a hydrogen atom or an alkyl group having 1-3 carbon atoms, R2 denotes a hydrogen atom, an alkyl group having 1-5 carbon atoms or an alkyloxy group having 1-5 carbon atoms, R3 denotes an alkyl group having 1-3 carbon atoms and n denotes 1-6 or a pharmaceutically acceptable acid addition salt thereof. They are active in prolonging urination intervals and increasing urination threshold pressure with almost no influence upon constrictive force of the bladder. Thus, they are effective in treatment and prevention of dysuria such as pollakiuria and incontinence of urine.
Patent IL-104891-A0 (IL)
Title: Cyclosporins,their preparation and pharmaceutical compositions containing them
IPC: A61K38/00
Filed: 1993-03-01
Abstract: Cyclosporins wherein the residue at the 1-position has the formula I   <CHEM> in which -x-y- is -CH=CH-(trans) or -CH2-CH2-, X is 0 or S and R is hydrogen, optionally halo or hydroxy substituted-C1-3-alkyl, -alkoxy or -alkylthio, or amino or mono- or di-(C1-2alkyl)-amino, useful as pharmaceuticals, preferentially for topical administration in particular for asthma therapy.
Patent IL-109113-A0 (IL)
IPC: E06B9/88
Filed: 1994-03-24
Abstract: The invention relates, in particular, to a motorised roller shutter comprising, on the one hand, a shutter (2) which is wound around and is unwound from a winding shaft (4) inside which is housed a geared drive motor (5), of the tubular type, and on the other hand, means (8) which deliver an electrical signal representing the movement of the shutter (2) and a unit (9) which processes the electrical signal and which can control the operation of the geared drive motor (5), in particular, in order to stop the latter in the event of an obstacle. This motorised roller shutter is characterised in that the said means (8) consist of at least one inductive sensor (10) extending, at least in part, along the path followed by the shutter (2), this inductive sensor (10) being capable of generating an electromotive force under the action of the passage of a permanent magnet (11) attached to the bottom part (12) of the shutter, this electromotive force being detected by the processing unit (9). <IMAGE>
Patent IL-109230-A0 (IL)
Title: Fungicidal compositions containing bifonazole
IPC: C07J5/00
Filed: 1994-04-05
Abstract: The invention provides a topical antifungal/corticosteroid composition which comprises bifonazole as a fungicide and fluocinonide as an anti-inflammatory steroid in a pharmaceutically acceptable vehicle.
Patent IL-110689-A0 (IL)
Title: Substituted aryloxyalkyl diamine derivatives, their preparation and pharmaceutical compositions containing them
IPC: A61P25/06
Filed: 1994-08-17
Abstract: PCT No. PCT/EP94/02702 Sec. 371 Date Feb. 5, 1996 Sec. 102(e) Date Feb. 5, 1996 PCT Filed Aug. 12, 1994 PCT Pub. No. WO95/05366 PCT Pub. Date Feb. 23, 1995The present invention is concerned with compounds having the formula    <IMAGE>  (I)  the pharmaceutically acceptable acid addition salts thereof, and the stereochemically isomeric forms thereof, wherein R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; R3 is C1-6alkyl, hydroxy, cyano, halo, C1-6alkyloxy, aryloxy, arylmethoxy, C2-6alkenyl, C2-6alkynyl, C1-6alkyl-S-, C1-6alkyl(S=O)-, C1-6alkylcarbonyl; R4 is hydrogen, halo, hydroxy, C1-6alkyl, or C1-6alkyloxy; or R3 and R4 taken together form a bivalent radical; R5 and R6 each independently are hydrogen, halo, hydroxy, C1-6alkyl, C1-6alkyloxy, aryloxy or arylmethoxy; R7 is hydrogen; Alk1 is C2-5alkanediyl; Alk2 is C2-15alkanediyl; Q is a heterocyclic ring containing at least one nitrogen atom or a radical of formula    <IMAGE>  (aa)  Pharmaceutical compositions, preparations and use as a medicine are described.
Patent IL-126273-A0 (IL)
Title: Cell culture media for mammalian cells
IPC: C12N5/02
Filed: 1997-03-12
Abstract: A chemically defined mammalian cell culture medium is provided that supports maintenance and long term clonal growth of mammalian hepatocytes and other cells.
Patent IL-133646-A0 (IL)
Title: Method for producing 2-(3-pyrazolyl-oxymethylene) nitrobenzenes
IPC: C07B39/00
Filed: 1998-07-20
Abstract: PCT No. PCT/EP98/04490 Sec. 371 Date Jan. 27, 2000 Sec. 102(e) Date Jan. 27, 2000 PCT Filed Jul. 20, 1998 PCT Pub. No. WO99/06373 PCT Pub. Date Feb. 11, 19992-(3-Pyrazolyloxymethylene)nitrobenzene [sic] derivatives of the formula I where the substituents and indices have the meanings given in the description, are prepared by bromination of an o-nitrotoluene of the formula II and subsequent reaction with a 3-hydroxypyrazole of the formula IV
Patent IL-147621-A0 (IL)
Title: A haemorrhoidal ligature applicator
IPC: A61B17/28
Filed: 2001-05-04
Abstract: The present invention relates to a medical device for applying resilient ligatures to haemorrhoids, commonly known as a haemorrhoidal ligature applicator. In particular, the present invention relates to a device for applying ligatures to haemorrhoids, comprising a barrel (3) provided with a grip (2) and having a distal end (9) which can receive resilient rings (7), a slidable actuator (5), operated by a trigger (4), being disposed on the outer surface of the barrel (3), the slidable actuator (5) being movable between a retracted position and an advanced position so as to cause the resilient ring (7) to be disengaged from the distal end (9) of the barrel (3) upon command. <IMAGE>
Patent IL-157046-A0 (IL)
Title: Phthalic acid diamide, method for the production thereof and the use of the same as a pesticide
IPC: A01N55/00
Filed: 2002-01-25
Abstract: The invention relates to novel phthalamides of the formula (I)in which disclosure. The invention further relates to a process for preparing these compounds and their use for controlling pests.
Patent IL-159620-A0 (IL)
Title: Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
IPC: A61K47/34
Filed: 2002-07-05
Abstract: Injectable formulation for diagnostics or photodynamic therapy contains up to 10 mg/ml alkali metal salt of an organopalladium complex (I) in aqueous carrier containing benzyl alcohol-ethanol mixture (ratio 15:85-25:75) or propylene glycol as photosensitizer solubilizing agent and up to 20 wt.% of a surfactant to decrease the aggregation of the photosensitizer. An injectable formulation for diagnostics or photodynamic therapy contains up to 10 mg/ml of an alkali metal salt of an organopalladium complex of formula (I) in an aqueous carrier containing a benzyl alcohol -ethanol mixture in the ratio 15:85-25:75 or propylene glycol as photosensitizer solubilizing agent and up to 20 wt.% (calculated on the weight of the final formulation) of a surfactant to decrease the aggregation of the photosensitizer. R2 = H, OH or COOR4; R3 = H, OH, or 1-12C alkyl; and R4 = H, 1-12C alkyl, or 3-12C cycloalkyl.
Patent IL-179704-A0 (IL)
Title: Method for producing optically active cyclopropanecarboxylate compound
Filed: 2006-11-29
Abstract: A process for production of an optically active cyclopropanecarboxylate compound represented by the formula (5):   
wherein R 6 , R 7 , R 8  and R 9  represent a C1-C6 alkyl group or the like and R 10  represents a C1-C6 alkyl group, 
which comprises reacting an olefin represented by the formula (3):   
wherein R 6 , R 7 , R 8  and R 9  are as described above, 
with a diazoacetic acid ester represented by the formula (4):  
N 2 CHCO 2 R 10 (4)  
wherein R 10  is as described above, 
in the presence of an asymmetric copper complex obtained by mixing 
(A) at least one monovalent or divalent copper compound, 
(B) at least one optically active bisoxazoline compound represented by the formula (1):   
wherein R 1  and R 2  represent a C1-C6 alkyl group or the like; R 3  represents a tert-butyl group or the like; and R 4  and R 5  are the same and represent C1-C3 alkyl groups or the like, and 
(C) at least one boron compound represented by the formula (2):     
wherein A represents a trityl group or the like, X represents a fluorine atom or the like, and n represents an integer of 1 to 5.
Patent IL-186202-A0 (IL)
Title: Device with engineered surface architecture coating for controlled drug release
Filed: 2007-09-24
Abstract: In one embodiment of the present invention a coating topology, or engineered surface architecture that may be referred to as a microdroplet deposited engineered surface architecture is provided. A plurality of drops are placed on the stent with the purpose, of building up individual units of coating material on the outer stent surface. This architecture results in a coating that uses less material, i.e., polymer, solvent, medicine, while at the same time providing for better, and determinable, drug kinetics, approaching 100% delivery and better mechanical operation of the coating binding to the stent.
Patent IL-201033-A0 (IL)
Title: Door lock
Filed: 2009-09-17
Abstract: The deadbolting means of the lock according to the invention comprise a locking piece (15) to establish and release the locking of the deadbolting means in the deadbolting position. The locking piece is pivotably supported on the lock body (3) and comprises a mechanical control part (19) and at least one electrical control part (20A, 20B). The mechanical control part is functionally linked to a mechanical controller. The electrical control part is functionally linked to an electric actuator.
Patent IL-220194-A0 (IL)
Title: Improvements in receivers for television signals
IPC: H04N21/433
Filed: 2012-06-05
Abstract: A television signal receiver for receiving and storing television signals encoded at a variable data rate. Time information is generated based on the time of receipt of the signals that defines the duration of the television signals when output in decompressed form at a substantially constant data rate. The received signals are then written to a file on a hard disk (13) in received order together with the time information. The time information of signals stored in the file is monitored and old signals are deleted from the file such that the file stores signals corresponding to a predetermined period of time.
Patent RO-125804-A0 (RO)
Title: Unattended installation for the detection and signalling of pedestrians
Inventor: ŞTEFAN BOGDAN DORIAN
IPC: G08G1/07
Filed: 2010-04-19
Abstract: The invention relates to an unattended installation for the detection and signalling of pedestrians. According to the invention, the installation comprises a detection system (4) mounted at the top part of some supports (1) located in the vicinity of a pedestrian crossing, which, by means of some presence sensors detects the presence of pedestrians in the area of the pedestrian crossing, both on the sidewalk and on the traffic road, the information provided by the presence sensors being transmitted to an assembly of control and distribution modules (3) which process the received information and send commands to a signalling system consisting of optical warning indicators (8) embedded into the traffic road, pedestrian crossing devices (6) placed on the supports (1) and at least two point and linear pedestrian systems (5 and 7) located above the pedestrian crossing devices (6), the operation of the detection and signalling systems being monitored by a monitoring device and the electric power needed for the said operation being provided by an autonomization module (2) consisting of a solar energy collecting panel, a charging controller and an electric power storage means.
Patent RO-132721-A0 (RO)
Title: Glazed tiles with photovoltaic potential for roofs
Inventor: POTERAŞ GEORGE
IPC: H01L31/042
Filed: 2018-03-15
Abstract: The invention relates to metallic tiles coated with glazes with photovoltaic potential for making good use of solar energy and to a process for manufacturing the same, the glazing of the said tiles also including secondary raw materials obtained from wastes recycling. According to the invention, the tile has some longitudinal slots (2) made on 2/3 of its length, it has a first thin glazing layer (3) with the role of cathode and a second thin layer (4) with the role of anode, both glazing layers, with semiconductor role, being doped with chemical elements of the groups III, IV and VII of the periodic table, it has a conductive layer (5) on the posterior side, in the slots (2) and on the upper side, over which the tile interconnecting bars (6) and the main band (7) for connecting the tile rows to one another, the slots (2) being filled with a material (8) with thermo- and hydro-insulating properties. As claimed by the invention, the process consists in coating the upper side of the tile (1), by spraying/brushing, with a thin layer (3) of glazing doped with chemical elements of the groups III-IV, the tile (1) is introduced into the furnace where it is heated from the ambient temperature up to 1000°C, kept for 15 min and then subjected to a slow cooling, a second thin layer (4) of glazing doped with elements of the group VII is applied by spraying/brushing, the tile (1) is reintroduced into the oven where it is subjected to the same thermal treatment as above, the posterior side, the slots (2) and the upper side of the tile (1) are coated with the conductive layer (5), over the conductive layers (5) the interconnecting bars (6) as well as the main band (7) for connecting the tile rows to one another are applied, and in the end the slots (2) are filled with a material with thermo- and hydro-insulating properties.
Patent AP-2002002465-A0 (AP)
Title: Use of GABAA inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or Vitamin E for the treatment of cognitive disorders.
Inventor: VILLALOBOS ANABELLA
IPC: C07D498/08
Filed: 2002-02-28
Abstract: A pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal comprising administration of a GABAA inverse agonist, or a pharmaceutically acceptable salt thefeof; and a nicotine receptor partial agonist, an estrogenic agent, selective estrogen receptor modulator or vitamin E or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. The GABAA inverse agonist, and nicotine receptor partial agonist, estrogen, selective estrogen receptor modulator or vitamin E are present in amounts that render the composition effective enhancing cognition or in the treatment of diseases of cognitive dysfunction including but not limited to Alzheimer's Disease (AD), mild cognitive impairment, age-related cognitive decline, vascular dementia, Parkinson's disease, Huntington's disease, memory impairment associated with depression or anxiety, schizophrenia, Down's syndrome, stroke, traumatic brain injury (TBI), AIDS associated dementia and attention deficit disorder. The method of using these compositions is also disclosed.
Patent AP-2003002933-A0 (AP)
Title: Insect repelling candle
Inventor: SHUKLA SANJIVKUMAR D
Filed: 2003-09-16
Abstract: Insect repellent candle for repelling insects, more particularly mosquitoes comprising of Thymol, Camphor, Eucalyptus oil, Cainammon oil, Neem seed oil and smalls and herbs in various percentage rations, incorporated into a solid medium candle. The said ingredients may optionally incorporate coloring matter in form of pigments and or dyes.
Patent MC-1528-A1 (MC)
Inventor: HUNKELER WALTER
IPC: C07D487/14
Filed: 1983-06-19
Abstract: There are described novel pharmaceutically active substances which have a pronounced affinity to the central benzodiazepine receptors and which have only a low toxicity. These active substances, namely imidazobenzodiazepines of the formula    <IMAGE>  I  wherein A is lower alkylene, n is zero or 1, R1 is lower alkynyl, lower alkenyl, aryl, (C3-8)-cycloalkyl optionally substituted by lower alkyl or (C5-8)-cycloalkenyl optionally substituted by lower alkyl, or a 5- or 6-membered saturated or unsaturated heterocycle which contains an oxygen or sulphur atom as a ring member and which is optionally substituted by lower alkyl, R4 and R5 each are hydrogen, halogen, trifluoromethyl, cyano, nitro, amino or lower alkyl and either R2 is hydrogen and R3 is lower alkyl or R2 and R3 together are dimethylene, trimethylene or propenylene, the compounds of formula I in which R2 and R3 together are dimethylene, trimethylene or propenylene having the (S) or (R,S) configuration with reference to the carbon atom denoted by  gamma , and their pharmaceutically acceptable acid addition salts, can be used as medicaments in the form of pharmaceutical preparations, especially in the control of convulsions and anxiety states and/or in the partial or complete antagonization of some or all activities which 1,4-benzodiazepines having tranquillizing activity or other substances display via the central benzodiazepine receptors.
Patent IE-910275-A1 (IE)
Title: Tablet-administering device for small animals
IPC: A61D7/00
Filed: 1991-01-25
Abstract: In order to permit a simple, safe and animal-friendly administration of medicaments in tablet form to small animals, use is made of a cylinder (1) with a ram (6), the outlet end of the cylinder (1) having an annular or discontinuously annular constriction (5), the tablets preferably being ejected at the outlet end only after surmounting of a counterforce by the constriction (5).
Patent MA-28259-A1 (MA)
Title: Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
Inventor: JEAN-LOUIS PEGLION
IPC: A61P25/00
Filed: 2006-04-03
Abstract: DERIVES DE PIPERAZINE, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT Composé de formule (I) : dans laquelle : - R1, R2, R3 et R4, identiques ou différents, représentent chacun un atome ou groupement choisi parmi H, halogène, alkyle, alkoxy, phényle et cyano, - X représente une liaison, un atome d'oxygène ou un groupement choisi parmi -(CH2)m-, -OCH2- et -NR5-, m représente 1 ou 2, R5 est tel que défini dans la description, - Y représente un atome d'oxygène ou un groupement choisi parmi NR7 et CHRs, où R7 et Rg sont tels que définis dans la description, - Z représente un atome d'azote ou un groupement CH, - n représente 1 ou 2, - Ak représente une chaîne alkylène, - Ar représente un groupement aryle ou hétéroaryle.  ses isomères optiques, ainsi que ses sels d'addition à un acide pharmaceutiquement acceptable. Médicaments.
Patent MA-40305-A1 (MA)
Title: Composition nématicide et son utilisation
Inventor: BRISTOW JAMES TIMOTHY
IPC: C05G3/60
Filed: 2015-10-20
Abstract: L'invention concerne une composition comprenant en tant que composant (a) au moins un insecticide ; et en tant que composant (b) au moins un engrais. La composition est efficace pour lutter contre les nématodes et pour favoriser la croissance des plantes. Ledit insecticide est choisi de préférence parmi le thiodicarbe, l'abamectine, l'imidaclopride, le fipronil et des mélanges de ceux-ci. Le composant engrais comprend de préférence un ou plusieurs acides aminés et un ou plusieurs micronutriments. L'invention concerne également un procédé pour lutter contre les nématodes et/ou favoriser la croissance des plantes en utilisant une combinaison du composant (a) et du composant (b).
Patent MA-40600-A1 (MA)
Title: Procédé et installation pour une production énergétiquement efficace, améliorée d'acide sulfurique
Inventor: DAUM KARL-HEINZ
IPC: C01B17/80
Filed: 2015-12-15
Abstract: L'invention concerne un procédé de production d'acide sulfurique par oxydation catalytique de so
Patent UY-25871-A1 (UY)
Title: Hidroximatos de sulfonamida
Inventor: DEALAET NANCY
IPC: A61P9/10
Filed: 1999-12-21
Abstract: La presente invención se refiere a determinados derivados de sulfonamida que son inhibidores de proteinasa C de tropocolágeno, a composiciones farmacéuticas que los contienen, a su utilización, a los productos intermedios de síntesis y a los métodos para obtener dichos compuestos. Estos compuestos de fórmula l en la que R1 significa alquilo, haloalquilo, heteroalquilo, cicloalquilo, arilo, aralquilo, aralquenilo, heteroarilo, amino disustituido, OH, etc; R es CH(R2)Ar1 o CH(R2)CH=CHAr1; Ar2 es un anillo fenilode fórmula ll, o bien un anillo naftilo de fórmula lll; y sus sales farmacéuticamente aceptables, fármacos latentes (prodrugs), isomeros individuales y mezclas de isómeros. Una composición farmacéutica que contiene una cantidad terapéuticamente eficaz de un compuesto de fórmula l y un excipiente farmacéuticamente aceptable. Utilización de un compuesto para la fabricación de un medicamento que consta de un compuesto para el tratamiento de la fibrosis pulmonar intersticial, fibrosis pericentral, fibrosis renal y hepatica, artritis fibrosis quistica, cirugía de tendones, cicatrices corneales y restenosis.
Patent UY-27349-A1 (UY)
Title: Nuevos derivados de 6-fenildihidropirrolpirimidindiona
Inventor: JUAN B VIDAL
IPC: A61P25/16
Filed: 2002-06-21
Abstract: Derivadops de 6-fenilpirrolpirimidindiona de fórmula (I), sales farmacéuticamente aceptables de los mismos, en donde R1, R2, R3, R4 y R5 son restos orgánicos, L1 es un grupo de enlace y R6 es -C(O)NR10R11,-S(O)2NR10R11, -ON=CR12R13, o un grupo heterocíclico,arilo o heteroarilo donde R10, R11, R12 y R13 son restos orgánicas, que tienen potencial terapéutico como inhibidores del receptor de adenosina A2.
Patent UY-27990-A1 (UY)
Title: Derivados de pirrolidona como inhibidores de maob
Inventor: JOLIDON SYNESE
IPC: C07D207/273
Filed: 2003-09-18
Abstract: Derivados de 4-pirrolidino racémicos o enantioméricamente puros, procesos para su preparación, composiciones farmacéuticas que comprenden dichos derivados, y su uso en la prevención y tratamiento de enfermedades, en particular las que están mediadas por inhibidores de la monoamino oxidasa B, en particular enfermedades de Alzheimer o demencia senil.
Patent UY-29122-A1 (UY)
Title: Serinamidas sustituidas por benzoilo
Inventor: ZAGAR DR CYRILL
IPC: A01N43/10
Filed: 2005-09-16
Abstract: La presente invención se refiere a serinamidas sustituidas por benzoilo de la fórmula I dnde las variables Het y R1 hasta R10 tienen los significados indicados en la descripción así como sus sales útiles en la agricltura; se comunican procedimientos y productos intermedios para su preparación, así como el uso de estos compuestos o de productos que contienen estos compuestos para combatir plantas indeseadas